Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganjuhuangtong Tablets for Early/Mid-Stage Knee Osteoarthritis with Effusion
ChiCTR2500112796Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ganjuhuangtong tablets in knee osteoarthritis (OA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Amount of knee joint cavity effusion in the affected limb at week 12. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
ganjuhuangtong tablets
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500112796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112796.